RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
 ALNY | Alnylam Pharmaceuticals, Inc. | $35.8b | $239.29 | -4.0% | 986.4K |
 ARWR | Arrowhead Research Corporation | $12.1b | $71.52 | -11.8% | 3.4M |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $10.2b | $46.85 | -8.8% | 4.6M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $0.9b | $4.45 | -2.6% | 1.7M |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $294.9m | $1.82 | -2.2% | 664.9K |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $275.9m | $7.95 | -1.6% | 89.9K |
 RNA | Atrium Therapeutics, Inc. Common Stock | $249.7m | $10.08 | -1.7% | 236.0K |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $238.5m | $4.12 | -4.5% | 123.4K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $12.9m | $1.02 | -1.9% | 106.3K |
 XCUR | Exicure, Inc. Common Stock | $8.1m | $1.28 | 0.0% | 14.5K |